US OptionsDetailed Quotes

VRCA241018P2500

Watchlist

0.95
+0.55+137.50%

15min DelayClose Oct 4 16:00 ET

0.95High0.95Low

Verrica Pharmaceuticals Stock Discussion

Stock_Drift

Yesterday 03:15

Unusual Volume Ticks. 10/3. 3:13pm EST.

$Houston American Energy (HUSA.US)$ $MicroAlgo (MLGO.US)$ $Kaixin Holdings (KXIN.US)$ $Verrica Pharmaceuticals (VRCA.US)$ $Indonesia Energy (INDO.US)$ $Wheeler Real Estate Investment Trust Inc (WHLR.US)$ $AMTD Digital (HKD.US)$ $Theriva Biologics (TOVX.US)$ $The Dixie Group (DXYN.US)$ $Elevai Labs (ELAB.US)$ $EVgo Inc (EVGO.US)$ $Power REIT (PW.US)$

Stock_Drift

Yesterday 00:37

Unusual Volume Ticks. 12:35pm EST. 10/3/24

$Pineapple Energy (PEGY.US)$ $AMTD Digital (HKD.US)$ $Wheeler Real Estate Investment Trust Inc (WHLR.US)$ $Indonesia Energy (INDO.US)$ $Rezolve AI (RZLV.US)$ $Gogoro (GGR.US)$ $Verrica Pharmaceuticals (VRCA.US)$ $EVgo Inc (EVGO.US)$ $Theriva Biologics (TOVX.US)$ $Elevai Labs (ELAB.US)$

Jaguar8

Oct 3 03:30

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure
- Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists
WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing med...

Boxman

Sep 11 17:15

$Verrica Pharmaceuticals (VRCA.US)$ looks like the bottom

Salmon Klein

Aug 21 05:49

$Verrica Pharmaceuticals (VRCA.US)$ why this guy dropped much? i am trying to make sense of it but can find a good reason...anyone inside?

Jaguar8

Aug 15 01:10

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma
Verrica Pharmaceuticals announced positive preliminary results from Part 2 of its Phase 2 clinical trial for VP-315, an investigational oncolytic peptide-based immunotherapy for basal cell carcinoma(BCC). Key findings include:
-...

Lonnie Quarles

Aug 14 22:45

$Verrica Pharmaceuticals (VRCA.US)$ what the hell is going on with this drop? market manipulation?

104420042

Aug 14 21:56

$Verrica Pharmaceuticals (VRCA.US)$ why this stock dropping so crazily?

Jaguar8

Aug 7 03:22

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
VRCA), a dermatology therapeutics company, has announced a conference call and webcast scheduled for August 14, 2024, at 8:30 a.m. ET. The event will cover two main topics:
1. The company's financial results for the second quarter ended June 30, 2024.
2....

Meltyy

May 22 15:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

No comment yet